Real-world utilization of once-daily extended-release abuse deterrent formulation of hydrocodone: a comparison with the pre-approval randomized clinical trials
Louise Taber,1 T Christopher Bond,2 Xuezhe Wang,2 Aditi Kadakia,2 Tracy J Mayne2 1Arizona Research Center, Phoenix, AZ, USA; 2Purdue Pharma L.P., Stamford, CT, USA Background and objective: Hydrocodone bitartrate extended release (Hysingla® ER, HYD) was previously...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-07-01
|
| Series: | Journal of Pain Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/real-world-utilization-of-once-daily-extended-release-abuse-deterrent--peer-reviewed-article-JPR |